We strive to stay at the forefront of biotechnological developments and to constantly incorporate innovation in our offerings – this is essential to be able to develop more reliable drug development platforms and avoid high drug attrition rates. Study director...
Innovation is not only part of InnoSer’s name but is central to its activities. We believe, the solution for the continuously high drug attrition rates resides in addressing the problem already at the preclinical stages of drug development. More specifically, we aim...
